These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 13810671)

  • 21. Some biochemical and electrophoretic studies on purified prothrombin, factor VII (proconvertin) and factor X (Stuart).
    TISHKOFF GH; PECHET L; ALEXANDER B
    Blood; 1960 May; 15():778-90. PubMed ID: 13838500
    [No Abstract]   [Full Text] [Related]  

  • 22. The complex pattern of response to coumarin drug therapy. The inadequacy of the prothrombin test as a guide to hypocoagulability.
    GOLLUB S; ULIN AW; LIKOFF W
    Am Heart J; 1962 May; 63():591-9. PubMed ID: 13899970
    [No Abstract]   [Full Text] [Related]  

  • 23. The role of the marrow in prothrombin and proconvertin synthesis.
    GORDIN R
    Acta Haematol; 1958 Jun; 19(6):341-6. PubMed ID: 13570906
    [No Abstract]   [Full Text] [Related]  

  • 24. The activity of plasma prothrombin and proconvertin in acute cholecystitis.
    AROSENIUS KE; SJOSTROM B
    Acta Soc Med Ups; 1960; 65():16-9. PubMed ID: 13794485
    [No Abstract]   [Full Text] [Related]  

  • 25. DO BARBITURATES INFLUENCE THE PROTHROMBIN-PROCONVERTIN LEVEL DURING ANTICOAGULANT THERAPY?
    SAMUELSSON SM; LILIENBERG G
    Scand J Clin Lab Invest; 1965; 17():73-9. PubMed ID: 14260757
    [No Abstract]   [Full Text] [Related]  

  • 26. Puerperal thrombosis, treatment with tromexan, control of prothrombin activity according to Pedrazzini, Salvidio and F. Koller.
    SCHELLENBERG W
    Praxis; 1953 Jul; 42(29):599-601. PubMed ID: 13088594
    [No Abstract]   [Full Text] [Related]  

  • 27. Measurement of overall coagulabity during coumar in treatment with reference to the Quick test.
    VERSTRAETE M; VERMYLEN C; VANDENBROUCKE J
    Acta Med Scand; 1960 Jun; 167():127-38. PubMed ID: 13841924
    [No Abstract]   [Full Text] [Related]  

  • 28. [Plasma prothrombin-proconvertin content following therapeutic doses of heparin].
    MUNCK O
    Ugeskr Laeger; 1956 Jan; 118(2):38-9. PubMed ID: 13312131
    [No Abstract]   [Full Text] [Related]  

  • 29. The control of prothrombin activity with tromexan therapy.
    WEINER M; SIMSON G; BURNS JJ; STEELE JM; BRODIE BB
    Am J Med; 1953 Jun; 14(6):689-93. PubMed ID: 13057878
    [No Abstract]   [Full Text] [Related]  

  • 30. Micromethod for quantitative determination of plasma prothrombin and proconvertin.
    DYGGVE H; LUND E
    Acta Med Scand; 1954; 150(3):207-14. PubMed ID: 13206681
    [No Abstract]   [Full Text] [Related]  

  • 31. [SOME PROBLEMS OF THE ANTICOAGULANT TREATMENT OF DEEP VENOUS THROMBOSIS IN PREGNANCY].
    FORGACS J; NEMETH L
    Orv Hetil; 1964 Jun; 105():1162-5. PubMed ID: 14160767
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison between micro-modifications of prothrombin-proconvertin determinations and of the prothrombin time method.
    DYGGVE H
    Scand J Clin Lab Invest; 1958; 10(1):1-4. PubMed ID: 13555683
    [No Abstract]   [Full Text] [Related]  

  • 33. [Associated deficiency of the antihemophilic B factor and of the prothrombin-proconvertin complex in infants].
    BERNHEIM M; GERMAIN D; FREYCON MT; RIEDWEG M; BRUNAT M
    Pediatrie; 1962; 17():423-7. PubMed ID: 13868174
    [No Abstract]   [Full Text] [Related]  

  • 34. [CHANGES IN THE BLOOD COAGULATION AND ANTICOAGULATION SYSTEM OF PATIENTS WITH CONGENITAL HEART DISEASES OF THE "BLUE TYPE"].
    GORODETSKAIA NM
    Vopr Okhr Materin Det; 1964 Mar; 9():21-3. PubMed ID: 14182338
    [No Abstract]   [Full Text] [Related]  

  • 35. DETERMINANTS OF THE CLOTTING FACTOR RESPONSE TO WARFARIN IN THE RAT.
    PYOERAELAE K
    Ann Med Exp Biol Fenn; 1965; 43():SUPPL 3:1-99. PubMed ID: 14342207
    [No Abstract]   [Full Text] [Related]  

  • 36. [PROTHROMBIN AND PROCONVERTIN INDICES IN BOTKIN'S DISEASE IN CHILDREN].
    TOLSTOVA TI; PROTOKLITOVA NS
    Vopr Okhr Materin Det; 1964 May; 9():38-41. PubMed ID: 14221572
    [No Abstract]   [Full Text] [Related]  

  • 37. [Evaluation of liver function by determination of factor V, factor VII and prothrombin; effects of synkavit and vitamin K1].
    FORELL MM; KOLLER F
    Munch Med Wochenschr; 1953 Apr; 95(15):433-7. PubMed ID: 13072403
    [No Abstract]   [Full Text] [Related]  

  • 38. Preparation of a human plasma fraction rich in prothrombin, proconvertin, Stuart factor, and PTC and a study of its activity and toxicity in rabbits and man.
    DIDISHEIM P; LOEB J; BLATRIX C; SOULIER JP
    J Lab Clin Med; 1959 Feb; 53(2):322-30. PubMed ID: 13621053
    [No Abstract]   [Full Text] [Related]  

  • 39. [Hepato-quick--a new thromboplastin time system: a comparison with normotest and thrombotest (author's transl)].
    Fischer M; Falkensammer C
    Wien Klin Wochenschr; 1974 Oct; 86(19):577-83. PubMed ID: 4432516
    [No Abstract]   [Full Text] [Related]  

  • 40. ["COAGULANT" FRACTIONS CONTAINING COAGULATION FACTORS ADSORBABLE BY TRICALCIC PHOSPHATE].
    SOULIER JP; BLATRIX C; STEINBUCH M
    Presse Med (1893); 1964 Apr; 72():1223-8. PubMed ID: 14134215
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.